Page 354 - Textbook of Pathology, 6th Edition
P. 354

338


























     SECTION II








           Figure 13.8  Pathophysiology of disseminated intravascular coagulation.

           CLINICAL FEATURES. There are 2 main features of DIC—  fragmented red cells due to damage caused by trapping
           bleeding as the most common manifestation, and organ  and passage through the fibrin thrombi.
           damage due to ischaemia caused by the effect of widespread
           intravascular thrombosis such as in the kidney and brain.  3. Prothrombin time, thrombin time and activated partial
           Less common manifestations include: microangiopathic  thromboplastin time, are all prolonged.
           haemolytic anaemia and thrombosis in larger arteries and  4. Plasma fibrinogen levels are reduced due to consump-
           veins.                                                tion in microvascular coagulation.
                                                                 5. Fibrin degradation products (FDPs) are raised due to
            LABORATORY FINDINGS. The laboratory investigations
            include the following:                               secondary fibrinolysis.
            1. The platelet count is low.                         A summary of important laboratory findings in
                                                                 common causes of haemostatic abnormalities is summed
            2. Blood film shows the features of microangiopathic
            haemolytic anaemia. There is presence of schistocytes and  up in Table 13.3.
     Haematology and Lymphoreticular Tissues


            TABLE 13.3: Major Laboratory Findings in Common Haemostatic Disorders.
               Disorder              Platelet Count  BT     PT       APTT      TT       FDPs     F-VIII    F-IX
            I.  VASCULAR DISORDERS
               Vascular purpuras         N         N        N         N         N      Absent      N        N
            II.  PLATELET DISORDERS
               1.  ITP                   ↓ ↓ ↓ ↓ ↓  ↑ ↑ ↑ ↑ ↑  N      N         N      Absent      N        N
               2.  Heparin               ↓ ↓ ↓ ↓ ↓  ↑ ↑ ↑ ↑ ↑  N      ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  Absent  N       N
               3.  TTP                   ↓ ↓ ↓ ↓ ↓  ↑ ↑ ↑ ↑ ↑  N      N         N      Absent      N        N
           III.  COAGULATION DISORDERS
               1.  Haemophilia A         N         ↑ ↑ ↑ ↑ ↑  N       ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  Absent  ↓ ↓ ↓ ↓ ↓  N
               2.  Haemophilia B         N         ↑ ↑ ↑ ↑ ↑  N       ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  Absent  N       ↓ ↓ ↓ ↓ ↓
               3.  von Willebrand’s      N         ↑ ↑ ↑ ↑ ↑  N       ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  Absent  ↓ ↓ ↓ ↓ ↓  N
               4.  Vit. K deficiency     N         ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  Absent  N    N
               5.  Liver disease         N         ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  N  Absent      N        N
           IV.  DIC                      ↓ ↓ ↓ ↓ ↓  ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  ↑ ↑ ↑ ↑ ↑  Present  ↓ ↓ ↓ ↓ ↓  ↓ ↓ ↓ ↓ ↓
   349   350   351   352   353   354   355   356   357   358   359